Search research articles
Contact Us
Filters
Showing results (81-90 of 105) with videos related to
Page
of 11
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association
|
July 3, 2025
Cost-effectiveness of fenofibrate versus standard care for reducing the progression of diabetic retinopathy: An economic evaluation based on data from the LENS trial
Graham Scotland, Mekazin Tsehaye, Caroline Styles, et al.
Health Technology Assessment (Winchester, England)
|
May 12, 2026
Fenofibrate and progression of retinopathy in adults with diabetes: the randomised placebo-controlled LENS trial
David Preiss, Jennifer Logue, Emily Sammons, et al.
Diabetes Care
|
July 21, 2018
Renal and Cardiovascular Risk According to Tertiles of Urinary Albumin-to-Creatinine Ratio: The Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT)
M Loredana Marcovecchio, Scott T Chiesa, Jane Armitage, et al.
JAMA Cardiology
|
February 2, 2018
Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals
Theingi Aung, Jim Halsey, Daan Kromhout, et al.
Archives of Internal Medicine
|
October 13, 2010
Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals
Robert Clarke, Jim Halsey, Sarah Lewington, et al.
Health Technology Assessment (Winchester, England)
|
March 12, 2021
The effect of statins on muscle symptoms in primary care: the StatinWISE series of 200 N-of-1 RCTs
Emily Herrett, Elizabeth Williamson, Kieran Brack, et al.
Zhonghua Xin Xue Guan Bing Za Zhi
|
May 9, 2013
[ACEI/ARB use among high risk patients with coronary heart disease in China: a cross-sectional study]
Jia-min Liu, Lei Ge, Jing Li, et al.
Chinese Medical Journal
|
July 18, 2012
Underuse of statins in patients with atherosclerotic ischemic stroke in China
Xi Li, Yan Gao, Jing Li, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 9, 2005
First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease
Colin Baigent, Martin Landray, Craig Leaper, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
February 24, 2006
The second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: a randomized controlled study of the biochemical safety and efficacy of adding ezetimibe to simvastatin as initial therapy among patients with CKD
Martin Landray, Colin Baigent, Craig Leaper, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 105) with videos related to
Sort By:
Page
of 11
Diabetic Medicine : a Journal of the British Diabetic Association
|
July 3, 2025
Cost-effectiveness of fenofibrate versus standard care for reducing the progression of diabetic retinopathy: An economic evaluation based on data from the LENS trial
Graham Scotland, Mekazin Tsehaye, Caroline Styles, et al.
Health Technology Assessment (Winchester, England)
|
May 12, 2026
Fenofibrate and progression of retinopathy in adults with diabetes: the randomised placebo-controlled LENS trial
David Preiss, Jennifer Logue, Emily Sammons, et al.
Diabetes Care
|
July 21, 2018
Renal and Cardiovascular Risk According to Tertiles of Urinary Albumin-to-Creatinine Ratio: The Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial (AdDIT)
M Loredana Marcovecchio, Scott T Chiesa, Jane Armitage, et al.
JAMA Cardiology
|
February 2, 2018
Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals
Theingi Aung, Jim Halsey, Daan Kromhout, et al.
Archives of Internal Medicine
|
October 13, 2010
Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals
Robert Clarke, Jim Halsey, Sarah Lewington, et al.
Health Technology Assessment (Winchester, England)
|
March 12, 2021
The effect of statins on muscle symptoms in primary care: the StatinWISE series of 200 N-of-1 RCTs
Emily Herrett, Elizabeth Williamson, Kieran Brack, et al.
Zhonghua Xin Xue Guan Bing Za Zhi
|
May 9, 2013
[ACEI/ARB use among high risk patients with coronary heart disease in China: a cross-sectional study]
Jia-min Liu, Lei Ge, Jing Li, et al.
Chinese Medical Journal
|
July 18, 2012
Underuse of statins in patients with atherosclerotic ischemic stroke in China
Xi Li, Yan Gao, Jing Li, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 9, 2005
First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease
Colin Baigent, Martin Landray, Craig Leaper, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
February 24, 2006
The second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: a randomized controlled study of the biochemical safety and efficacy of adding ezetimibe to simvastatin as initial therapy among patients with CKD
Martin Landray, Colin Baigent, Craig Leaper, et al.
Page
of 11